Emergency Use of OCR-002 in Acute Liver Failure (ALF)

Status No longer available

Clinical Trial Summary

This study provides emergency use of the unapproved study medication in ALF patients with acute liver failure who are not responding to standard of care.

Clinical Trial Description

This is an open-label study in patients diagnosed with ALF who are not responding to the institution's standards of care. Standard of care may include, but is not limited to, administration of N-acetylcysteine, lactulose, hypothermia therapy, and consideration for orthotopic liver transplant. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01634230
Study type	Expanded Access
Source	Mallinckrodt
Contact
Status	No longer available
Phase

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05491135` - Hepatocyte Microbeads for Acute Liver Failure	Phase 1/Phase 2
Terminated	`NCT01937130` - Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF	Phase 2
Withdrawn	`NCT05940610` - The Safety and Efficacy of MSC-EVs in Acute/Acute-on-Chronic Liver Failure	Phase 1/Phase 2
Terminated	`NCT01875874` - Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)	Phase 2
Not yet recruiting	`NCT01435421` - Breath Test for Patients With Acute Liver Disease for Early Detection of the Need for Transplant or Recovery	N/A
Completed	`NCT00245310` - Indocyangreen Elimination in Cirrhosis and Acute Liver Failure	N/A
Withdrawn	`NCT03629015` - Safety Study of Stemchymal® in Acute Liver Failure	Phase 1
Recruiting	`NCT04621812` - Role of Fecal Microbiota in Predicting Graft Rejection and Sepsis Among Recipients of Living Donor Liver Transplant in First Year.
Active, not recruiting	`NCT02833064` - Biomarkers in Liver Failure
Not yet recruiting	`NCT06285253` - miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial	Phase 1
Recruiting	`NCT03882346` - Study to Evaluate Safety and Efficacy of LifeLiver in Acute or Acute-on-Chronic Liver Failure Patients	Phase 2
Recruiting	`NCT05689645` - F573 for Injection for the Treatment of Liver Injury/Failure	Phase 2
Not yet recruiting	`NCT05772585` - Characterization of Metabolomic Fingerprints in Patients With Acute Liver Failure and Acute-on-chronic Liver Failure With Hepatic Encephalopathy
Completed	`NCT00655304` - The Effect of Prometheus (R) Liver Support Dialysis on Cerebral Metabolism in Acute Liver Failure	N/A
Completed	`NCT00059267` - Prevention of Recurrent Hepatitis B After Liver Transplantation	N/A
Active, not recruiting	`NCT05413083` - Evaluation of Cardiac Function in Acutely Decompensated Cirrhosis
Recruiting	`NCT05146336` - CytOSorb TreatMent Of Critically Ill PatientS Registry
Withdrawn	`NCT04089969` - Cardiac Risk Assessment Using Standard of Care Versus CTA and Heart Flow FFRct	N/A
Completed	`NCT02460510` - Role of Hypertonic Saline Versus Mannitol in the Management of Raised Intracranial Pressure in Patients With ALF	N/A
Completed	`NCT01872767` - Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver Failure	N/A